CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Scientific Officer acquired 74,420 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Option exercise President and CEO acquired 10,000 shares (option exercise)
- 4/A Option exercise President and CEO acquired 10,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise VP of Finance and Controller acquired 2,274 shares (option exercise)
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise VP of Finance and Controller acquired 2,274 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 10,720 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
Page 12 of 17 · 326 filings